of water masses.
The problem is that researchers are largely limited to areas where ships already travel. When it comes to the remote polar regions, especially the Antarctic, there is a dearth of data.
"There are a few floats out there but not much else," says Lars Bohme, an oceanographer who has been working with Fedak's team at the University of St Andrews, UK. "There's a need for real-time data from this area, to develop models that in the short term can help predict weather and in the long term, climate change. Compared with other techniques for creating transgenic animal models, such as adding or deleting genes from embryonic cells and then breeding the animals that develop, the process is quick. "We can create these models in months rather than years, " says Déglon. "And we can replicate the damage seen in late stages of disease, which is not often seen in other transgenic models. "
Déglon is now writing up results from a macaque Huntington model. She says her team has observed motor deficits such as muscle contractions that are typical of the condition, and that post-mortem analysis of brain tissue shows the gene causes damage similar to that seen in humans.
The ability to create primate models using this technique has persuaded others to use viral vectors. Deniz Kirik, a colleague of Bjorklund's at Lund, is finishing a three-year study in which he tracked marmosets infected with a mutant version of the gene for alpha-synuclein -the protein involved in Parkinson's disease. He says the model, the first transgenic primate model of the disease, recreates human symptoms well. The technique also allowed him to use a new control in his experiment: by injecting the faulty gene into just one side of the marmosets' brain, he was able to show that movement problems only developed on the side of the body controlled by that part of the brain.
Other primate models of Parkinson's have used chemicals to kill the neurons that are normally damaged by the disease. "This model is much better -the pathology is driven by mechanisms similar to those in humans, " says Kirik.
Such advantages mean that the use of viralvector models is likely to grow beyond the ten or so groups that have taken them up over the past few years. But Bjorklund notes that the technique will not replace traditional transgenic models. For example, conventional techniques allow large numbers of animals with identical mutations to be bred, which is useful for drug screening. The surgical skills needed to inject the virus into the correct brain areas are also difficult, adds Bjorklund, and may put off some labs.
■
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Ahead of the pack: seals with satellite tags could gather data from oceans where few ships venture.
